drugset / Trial / NCT02287818
A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout
RandomizedParallel-groupDouble-blindTreatment
Summary
The study is designed to test the urate-lowering effect, safety, and tolerability of AC-201CR in an initial dosing period, followed by the addition of a ULT to test the efficacy and safety of the combination and prophylaxis of gout flares during ULT.
Timeline
- Start
- 2014-12
- Primary completion
- 2016-10-27
- Completion
- 2016-10-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diacerein | Small molecule | 100 mg | — |
| Background | Febuxostat | Small molecule | 80 mg | — |